Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.
Journal: Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of America
Published:
Abstract
After BNT162b2 messenger RNA vaccination, antibody levels to spike, receptor-binding domain, and virus neutralization were examined in 149 nursing home residents and 110 healthcare worker controls. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-naive nursing home residents' median post-second vaccine dose antibody neutralization titers are one-quarter that of SARS-CoV-2-naive healthcare workers.
Authors
David Canaday, Lenore Carias, Oladayo Oyebanji, Debbie Keresztesy, Dennis Wilk, Michael Payne, Htin Aung, Kerri St Denis, Evan Lam, Christopher Rowley, Sarah Berry, Cheryl Cameron, Mark Cameron, Brigid Wilson, Alejandro Balazs, Stefan Gravenstein, Christopher King
Relevant Conditions